Sensor-based Congestion ALert for Events in Peritoneal Dialysis (SCALE-PD)
NCT ID: NCT07059962
Last Updated: 2025-11-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
125 participants
OBSERVATIONAL
2025-09-09
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PD Patients
Patients with kidney disease on peritoneal dialysis.
Bodyport Cardiac Scale
The Bodyport Cardiac Scale captures several physiological signals, which are used to derive multiple biomarkers that reflect a user's hemodynamic and fluid status.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bodyport Cardiac Scale
The Bodyport Cardiac Scale captures several physiological signals, which are used to derive multiple biomarkers that reflect a user's hemodynamic and fluid status.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Able to speak and read English, or able to speak and read Spanish and has a caregiver or family member who speaks English and can provide assistance
3. Able to stand on two bare feet unassisted
4. Receiving automated peritoneal dialysis for the treatment of ESKD
5. Followed on the Vantive Sharesource Remote Patient Management Platform
Exclusion Criteria
2. Have a life expectancy of less than 12 months
3. Are pregnant or plan to become pregnant during the next 12 months
4. Weigh greater than 375 lbs
5. Planned kidney transplant within the next 12 months
6. Have an implanted neurostimulator system
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bodyport Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Desert Cities Dialysis
Victorville, California, United States
Southeastern Clinical Research Institute
Augusta, Georgia, United States
aQua Research Institute, LLC
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Heberto Schramm
Role: primary
Jaewon Lee
Role: primary
Rocio Hernandez
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CP-ScalePD-01
Identifier Type: -
Identifier Source: org_study_id